Locoregional failure and the risk of distant metastasis after modern radiotherapy for head and neck cancer

Head and Neck

Volumn 35, Issue 3, 2013, Pages 381-387

  Dragovic, Aleksandar F ^a   Caudell, Jimmy J ^a,b   Spencer, Sharon A ^a   Carroll, William R ^c   Nabell, Lisle A ^d   Bonner, James A ^a  

^a The University of Alabama at Birmingham   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

chemotherapy; distant metastasis; head and neck cancer; locoregional failure; radiotherapy

Indexed keywords

CETUXIMAB; TIRAPAZAMINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874109149     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.22977     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130.
2. Kramer S, Marcial VA, Pajak TF, MacLean CJ, Davis LW,. Prognostic factors for loco/regional control and metastasis and the impact on survival. Int J Radiat Oncol Biol Phys 1986; 12: 573-578.
3. Leibel SA, Scott CB, Mohiuddin M, et al. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 1991; 21: 549-556.
4. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48: 7-16.
5. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21: 92-98.
6. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-578.
7. Pignon JP, le Maitre A, Maillard E, Bourhis J,; MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4-14.
8. Bourhis J, Overgaard J, Audry H, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006; 368: 843-854.
9. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
10. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
11. Hellman S,. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol 1994; 12: 2229-2234.
12. Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007; 357: 1705-1715.
13. Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007; 357: 1695-1704.
14. Dragovic AF, Bonner JA, Spencer SA, Nabell LM, Carroll WR, Caudell JJ,. Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer. Head Neck 2011; 33: 1551-1556.
15. Kaplan EL, Meier P,. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
16. Mantel N,. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
17. Cox DR,. Regression models and life-tables (with discussion). J R Stat Soc [B] 1972; 34: 187-220.
18. Merino OR, Lindberg RD, Fletcher GH,. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1977; 40: 145-151.
19. Peltier LF, Thomas LB, Barclay TH, Kremen AJ,. The incidence of distant metastasis among patients dying with head and neck cancers: an analysis of 200 autopsies. Surgery 1951; 30: 827-833.
20. O'Brien PH, Carlson R, Steubner EA Jr, Staley CT,. Distant metastases in epidermoid cell carcinomas of the head and neck. Cancer 1971; 27: 304-307.
21. Fuks Z, Leibel SA, Wallner KE, et al. The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. Int J Radiat Oncol Biol Phys 1991; 21: 537-547.
22. Lefebvre J, Pointreau F, Rolland M, et al. Sequential chemoradiotherapy (SCRT) for larynx preservation (LP): preliminary results of the randomized phase II TREMPLIN study. J Clin Oncol 2009; 27: 15s (suppl; abstr 6010).